Attached files
| file | filename |
|---|---|
| EX-31 - PetLife Pharmaceuticals, Inc. | ex31.htm |
| 10-Q - PetLife Pharmaceuticals, Inc. | form10q.htm |
Exhibit 32
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
I, Sebastian Serrell-Watts, Chief Executive Officer and Chief Financial Officer of PetLife Pharmaceuticals, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Quarterly Report on Form 10-Q of the Company for the period ended February 28, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: July 17, 2018 | By: | /s/ Sebastian Serrell-Watts |
| Chief Executive Officer and Chief Financial Officer | ||
| (Principal Executive Officer and Principal Accounting Officer) |
The certifications set forth above are being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to PetLife Pharmaceuticals, Inc. and will be retained by PetLife Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.